Unlisted Deals:
×

Premier Cryogenics Annual Reports, Balance Sheet and Financials

Last Traded Price 295.00 + 0.00 %

Premier Cryogenics Limited (Premier Cryogenics) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
Premier Cryogenics Limited

Premier Cryogenics Limited Consolidated Balance Sheet (Rs in Lakhs)

Particulars

31-03-2025

31-03-2024

Non-current assets

 

 

Property, Plant and Equipment

3,286.66

3,179.98

Capital Work-in-Progress

31.76

54.43

Investments

109.20

109.20

Other financial assets

594.16

672.93

Other Non-current Assets

38.76

307.94

Current assets

 

 

Inventories

145.07

145.83

Investments

4,793.89

4,180.71

Trade Receivables

3,740.05

3,402.01

Cash and Cash Equivalents

204.97

43.80

Other Bank Balances

412.17

274.87

Other Current assets

350.03

245.88

Total Assets

13,706.98

12,617.57

Equity

 

 

Equity Share Capital

500.67

500.67

Other Equity

10,546.74

9,334.77

Non-Current Liabilities

 

 

Borrowings

57.61

171.18

Provisions

38.10

36.51

Deferred Tax Liabilities (Net)

114.35

167.32

Other non-current liabilities

538.92

556.93

Current Liabilities

 

 

Borrowings

1,264.02

1,161.12

Trade payables

104.01

179.88

Other Current Financial Liabilities

10.59

10.41

Other Current Liabilities

378.85

342.58

Provisions

95.01

90.50

Current Tax Liabilities (Net)

58.12

65.70

Total Equity and Liabilities

13,706.98

12,617.57

Premier Cryogenics Limited Consolidated Profit & Loss Statement (Rs in Lakhs)

Particulars

31-03-2025

31-03-2024

Revenue from operations

7,465.46

7,300.88

Other income

375.35

372.80

Total Income

7,840.81

7,673.68

Expenses

 

 

Cost of materials consumed

757.59

797.43

Purchases of stock-in-trade

710.46

830.71

Changes in inventories of Finished goods, work-in-process

and stock-in-trade

11.20

-8.27

Employee Benefit Expenses

783.91

707.70

Finance Costs

122.33

147.31

Depreciation and Amortisation Expenses

496.12

469.03

Other expenses

3,300.19

3,163.15

Total Expenses

6,181.80

6,107.06

Profit/(Loss) before tax

1,659.01

1,566.62

Tax expenses:

 

 

Current Tax

408.83

320.63

Deferred tax

-52.97

26.12

Profit / (Loss) for the year

1,303.16

1,219.87

Earnings per Share

26.47

24.77

Premier Cryogenics Limited Consolidated Cash Flow Statement (Rs in Lakhs) 

Particulars

31-03-2025

31-03-2024

Cash flow from operating activites

 

 

Net Profit before tax

1,659.01

1,566.62

Adjustments for non Cash/ Non trade items:

 

 

Depreciation & Amortization Expenses

496.12

469.03

(Profit) / loss on sale of property

-0.15

-

Interest income

-64.72

-62.33

Other non operating income

-13.13

-21.01

Gain on sale of investment

-297.50

-289.46

Operating profit / (loss) before working capital changes

1,779.63

1,662.85

Adjustments:

 

 

Inventories

0.76

-2.56

Trade receivables

-338.03

-132.68

Other Current Assets

-104.42

-4.30

Provisions

6.18

22.61

Trade payable & current liabilities

-39.42

96.68

Cash generated from operations

1,304.61

1,642.60

Net income tax (paid)

-433.73

-268.34

Net cash flow from / (used in) operating activities

870.88

1,374.26

Cash flow from investing activities

 

 

Acquisition of Fixed Assets

-32.95

-517.44

Disposal of Fixed Assets

1.45

-

Investment in capital work-in-progress

-548.48

-22.62

(Increase)/Decrease in Non Current Assets

269.17

-189.33

(Increase)/Decrease in Investments

-534.41

-408.86

Interest Income

64.72

62.33

Gain on sale of Investments

297.50

289.46

Other Operating Revenue

13.13

21.01

Net cash flow from / (used in) investing activities

-469.86

-765.46

Cash flow from financing activities

 

 

Increase in Borrowings

-10.67

-1020.12

Dividend and Dividend Tax paid

-73.86

-73.86

Increase/Decrease in other non current liabilities

-18.01

323.15

Net cash flow from / (used in) financing activities

-102.54

-770.84

Net increase / (decrease) in Cash and cash equivalents

298.48

-162.04

Cash and cash equivalents at the beginning of the year

318.66

480.70

Cash and cash equivalents at the end of the year

617.13

318.67

Here is a summary of the Cash Flow Statement for the years 2025 and 2024:

Operating Activities:

In FY 2025, net profit before tax rose to ₹1,659.01 lakh from ₹1,566.62 lakh in FY 2024, supported by higher operating profits. However, unfavorable working capital changes—particularly increases in trade receivables and other current assets—reduced cash from operations to ₹1,304.61 lakh from ₹1,642.60 lakh. After higher tax payments, net operating cash flow declined to ₹870.88 lakh from ₹1,374.26 lakh.

Investing Activities:

The company continued to invest heavily, with ₹548.48 lakh in capital work-in-progress and ₹534.41 lakh in investments. Proceeds from the sale of investments and other income offset part of this outflow, reducing net cash used in investing to ₹469.86 lakh, an improvement from ₹765.46 lakh in 2024.

Financing Activities:

Financing outflows fell sharply to ₹102.54 lakh from ₹770.84 lakh due to minimal debt repayment and stable dividend payouts. This indicates better cash retention in financing operations.

Net Cash Flow and Cash Position:

Overall cash increased by ₹298.48 lakh in FY 2025 versus a decline of ₹162.04 lakh in FY 2024, lifting closing cash to ₹617.13 lakh. The improvement was driven by lower investing and financing outflows, despite reduced operating cash inflows.

Financial Ratios of Premier Cryogenics Limited

Particulars

2025

2024

Current ratio

5.05

4.48

Debt Equity Ratio

0.12

0.14

Debt Service Coverage

7.17

2.29

Return on Equity

12.48%

13.17%

Inventory Turnover

51.33

50.51

Trade Receivables turnover ratio

2.09

2.19

Trade Payables turnover ratio

33.63

30.02

Net capital turnover ratio

1.05

1.23

Net profit ratio

17.46%

16.71%

Return on Capital employed

15.96%

17.13%

Return on Investment

6.63%

7.31%

Here is a summary of the financial ratios for Premier Cryogenics Limited for the year 2025 and 2024:

Current Ratio:

The current ratio improved to 5.05 in FY 2025 from 4.48 in FY 2024, indicating a very strong liquidity position. This means the company has over five times the current assets needed to meet its short-term obligations. While this reflects low liquidity risk, such a high ratio may also indicate underutilized assets that could otherwise be invested for higher returns.

Debt-Equity Ratio:

The debt-equity ratio declined slightly from 0.14 in FY 2024 to 0.12 in FY 2025, showing reduced reliance on debt financing. This low gearing ratio indicates financial stability and low interest burden, but also suggests the company might be underleveraged and could potentially take on more debt to fund expansion without significantly increasing financial risk

Debt Service Coverage Ratio (DSCR):

The DSCR rose sharply to 7.17 in FY 2025 from 2.29 in FY 2024, reflecting a substantial improvement in the company’s ability to cover debt obligations from operating earnings. A ratio well above 1 indicates comfortable debt servicing capacity, and such a high level highlights strong operational cash flow relative to debt repayment needs.

Return on Equity:

ROE decreased slightly from 13.17% in FY 2024 to 12.48% in FY 2025, indicating a marginal decline in the profitability generated from shareholders’ equity. While still healthy, the fall suggests either higher equity base or slightly lower net earnings relative to equity investment.

Inventory Turnover Ratio:

Inventory turnover improved marginally to 51.33 from 50.51, suggesting faster movement of inventory and efficient stock management. High turnover reflects strong sales or effective production planning, reducing the risk of inventory obsolescence.

Trade Receivables Turnover Ratio:

This ratio slipped from 2.19 in FY 2024 to 2.09 in FY 2025, indicating slightly slower collection of receivables. While the change is small, it may point to marginally higher credit periods extended to customers, potentially affecting cash flow.

Trade Payables Turnover Ratio:

The trade payables turnover increased from 30.02 in FY 2024 to 33.63 in FY 2025, implying that the company is settling its supplier obligations more quickly. While this reflects strong liquidity and supplier relationships, it might also reduce opportunities to optimize working capital through extended credit terms.

Net Capital Turnover Ratio:

The ratio fell from 1.23 in FY 2024 to 1.05 in FY 2025, indicating a slight decline in the efficiency of using working capital to generate sales. This could be due to an increase in current assets or a decline in sales growth relative to working capital employed.

Net Profit Ratio:

Net profit margin increased to 17.46% in FY 2025 from 16.71% in FY 2024, reflecting improved cost control or higher operational efficiency. This improvement suggests that the company is generating more profit per unit of revenue.

Return on Capital Employed – ROCE:

ROCE decreased from 17.13% to 15.96%, indicating slightly reduced efficiency in generating returns from the total capital (debt plus equity) employed. This may be due to higher capital investment without a proportionate increase in earnings.

Return on Investment (ROI):

ROI declined from 7.31% in FY 2024 to 6.63% in FY 2025, suggesting a slight drop in the returns generated from the company’s total investments. This could reflect lower profitability or a shift towards more long-term investments that have not yet yielded full returns.


Premier Cryogenics Annual Report

Premier Cryogenics Annual Report 2024-25

Download

Premier Cryogenics Annual Report 2022-23

Download

Premier Cryogenics Annual Report 2021-22

Download

Premier Cryogenics Annual Report 2020-21

Download

Premier Cryogenics Annual Report 2019-20

Download
Support Puja Support Ishika Support Purvi

News Alert